-
Pan-RAS Inhibitor Offers Hope of Improved Pancreatic Cancer Prognosis
Bio-IT World | A consortium of pancreatic cancer researchers sharing information in real time has shown that an oral pan-RAS inhibitor known as RMC-7977, developed by Revolution Medicines, effectively targets the common cancer-causing RAS proteins while minimally impacting normal cells—and did so across a comprehensive range of preclinical models in a series of similar experiments.
May 30, 2024
-
Ambry Genetics, PacBio Take on Rare Diseases, Regeneron Makes TOP500 List, More
Bio-IT World | Ambry Genetics and PacBio to support the Pediatric Mendelian Genomics Research Center (MGRC) program to better understand the underlying biology of rare diseases; Recursion’s BioHive-2 was dubbed No. 35 on the latest TOP500 list of the world’s fastest supercomputers; the Catalogue of Somatic Mutations in Cancer (COSMIC) launches its 100th version; more.
May 29, 2024
-
Follow the Money: Funds for Alzheimer’s Research, CN Bio Accelerates Oncology Products, More
Bio-IT World | Laurence Belfer gifts funds to MD Anderson Cancer Center to strengthen neurodegeneration research through the Belfer Neurodegeneration Consortium; CN Bio plans to accelerate its expanding product portfolio; more.
May 28, 2024
